Literature DB >> 2258628

Interleukin-1 and interleukin-6 in psoriasis.

E P Prens1, K Benne, J van Damme, M Bakkus, K Brakel, R Benner, T van Joost.   

Abstract

We report on the levels of expression of IL-1 and IL-6 in skin from psoriasis patients. Different approaches were pursued. Initially, the levels of IL-1 beta and IL-6 were measured in suction blister fluid from lesional and uninvolved skin from psoriasis patients, using a sensitive enzyme-linked immunoabsorbent assay (ELISA) and bio-assay. Skin sections were also examined for the presence of IL-1 and IL-6 using IL-1 beta- and IL-6-specific antibodies. Finally, the expression of IL-1 and IL-6 mRNA was determined in cultured keratinocytes (KC) and fibroblasts from psoriasis skin. Suction blister fluid from lesional and uninvolved psoriasis skin and from skin of healthy individuals did not contain detectable levels (greater than 100 pg/ml) of IL-1 beta. Blister fluid from psoriasis lesions contained low but significant levels of IL-6, whereas the serum levels of IL-6 in these patients was undetectable. Using cryostat skin sections and an IL-1 beta-specific monoclonal antibody (MoAb) in an indirect immunoperoxidase technique, a diffuse staining in the entire epidermis was observed in sections of uninvolved skin from psoriasis patients. In cryostat sections of psoriasis lesions, a faint diffuse staining of the epidermis and a pronounced "dot-like" intracellular staining pattern was observed. On the other hand, the same IL-1 beta-specific MoAb showed, in a indirect immunofluorescence technique using unfixed epidermal cells, bright membrane staining in epidermal cell suspensions from psoriasis lesions. Slightly elevated levels of IL-1 beta and IL-1 alpha mRNA were observed in cultured KC from psoriasis lesions as compared to those in normal KC and in the HEp-2 cell line. Very low levels of IL-6 mRNA were expressed in KC from psoriasis lesions and healthy individuals. Fibroblasts from psoriasis lesions expressed extremely low levels of IL-1 alpha and IL-1 beta, but high levels of IL-6 mRNA. The results point to a paradoxical situation in psoriatic skin: blister fluid from psoriasis lesions contains no IL-1 beta, whereas IL-1 beta is overexpressed on the plasma membrane and in the intracellular compartment of epidermal cells. This finding may help in explaining the observed absence of IL-1 in aqueous extracts of psoriatic scales. Because cultured KC from psoriasis lesions express minimal levels of IL-6 mRNA. dermal fibroblasts, probably together with the inflammatory infiltrate, may represent a major source of IL-6 in psoriasis lesions in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2258628     DOI: 10.1111/1523-1747.ep12874991

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  15 in total

1.  Expression, topography, and function of integrin receptors are severely altered in keratinocytes from involved and uninvolved psoriatic skin.

Authors:  G Pellegrini; M De Luca; G Orecchia; F Balzac; O Cremona; P Savoia; R Cancedda; P C Marchisio
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

2.  Adhesion molecules and IL-1 costimulate T lymphocytes in the autologous MECLR in psoriasis.

Authors:  E Prens; K t Hooft-Benne; B Tank; J Van Damme; T van Joost; R Benner
Journal:  Arch Dermatol Res       Date:  1996-02       Impact factor: 3.017

3.  Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas.

Authors:  J Bujía; C Kim; P Ostos; E Kastenbauer; L Hültner
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

4.  Interleukin-1 beta upregulates tissue-type plasminogen activator in a keratinocyte cell line (HaCaT).

Authors:  J M Rox; J Reinartz; M D Kramer
Journal:  Arch Dermatol Res       Date:  1996-08       Impact factor: 3.017

5.  Feasibility of in vitro culturing of lesional psoriatic keratinocytes in medium containing high calcium concentrations.

Authors:  Y Miyauchi; Y Mitsuhashi; T Kikuchi; I Hashimoto
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

6.  Pathogenic function of IL-1 beta in psoriasiform skin lesions of flaky skin (fsn/fsn) mice.

Authors:  M Schön; C Behmenburg; D Denzer; M P Schön
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

7.  Detection of inflammatory cytokines in psoriatic skin.

Authors:  Y Yoshinaga; M Higaki; S Terajima; E Ohkubo; T Nogita; N Miyasaka; M Kawashima
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

8.  Interleukin-6 in psoriasis: expression and mitogenicity studies.

Authors:  J T Elder; C I Sartor; D K Boman; S Benrazavi; G J Fisher; M R Pittelkow
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

9.  Interleukin 6 and 8 levels in plasma and fibroblast cultures in psoriasis.

Authors:  Anna Zalewska; Ewa Głowacka; Janina Wyczółkowska; Henryk Tchórzewski; Joanna Narbutt; Anna Sysa-Jedrzejowska
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

10.  Evidence for local inflammation in complex regional pain syndrome type 1.

Authors:  Frank J P M Huygen; Anke G J De Bruijn; Martha T De Bruin; J George Groeneweg; Jan Klein; Freek J Zijlstra
Journal:  Mediators Inflamm       Date:  2002-02       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.